Inpharma Weekly

, Volume 1216, Issue 1, pp 14–14 | Cite as

COX-2 inhibitors

benefits over conventional NSAIDs apparent
Newsletter Article
  • 2 Downloads

Keywords

Celecoxib Naproxen American Medical Association Rofecoxib Nabumetone 

Copyright information

© Adis International Ltd 1999

Personalised recommendations